newsfilter
← Latest News
ACCESS Newswire·

Helix Biopharma Corp. Announces Fiscal 2022 Second Quarter Results

RICHMOND, ON / ACCESSWIRE / March 16, 2022 / Helix BioPharma Corp. (TSX:HBP), (" Helix " or the " Company "), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology based on its proprietary technological pl